Defense Secretary Pete Hegseth has ordered testosterone level testing for military personnel over 30 as part of the Pentagon's periodic health assessment program. The directive, announced this week, aims to ensure optimal performance and long-term health among warfighters, according to the Defense Department.
The policy marks a departure from previous military health screening practices, which did not include routine hormone level monitoring. Hegseth has framed the initiative as part of broader efforts to assess and maintain troop readiness standards.
What the Right Is Saying
Conservative supporters of the policy argue that maintaining peak physical conditioning among deployed forces is a legitimate defense priority. Republican lawmakers have largely backed Hegseth's approach, with several citing concerns about declining military recruitment and retention metrics in recent years.
Senator Roger Wicker of Mississippi, chairman of the Senate Armed Services Committee, said he supports exploring every avenue to assess troop health. "Our men and women in uniform deserve comprehensive health monitoring," Wicker said in a statement. "If testosterone screening can identify health issues early, that's worth implementing."
The Heritage Foundation's defense policy team has argued that physical standards are essential to military readiness and that Hegseth is right to examine all factors affecting troop performance. Some conservative commentators have framed the initiative as part of a broader effort to reverse perceived declines in military preparedness under previous administrations.
Proponents note that the Pentagon already conducts various health screenings, including cholesterol checks, blood pressure monitoring, and vision exams for personnel over specific ages. They argue testosterone screening follows this established precedent.
What the Left Is Saying
Democratic lawmakers and progressive advocacy groups have raised concerns about the scientific basis for the mandate. Representative Adam Smith of Washington, ranking member of the House Armed Services Committee, said the directive raises questions about whether testosterone levels are a reliable indicator of military fitness.
The American Medical Association has not issued a formal statement on the policy but has previously noted that testosterone levels naturally vary based on age, health conditions, and other factors unrelated to job performance. Critics argue that without clear evidence linking specific hormone thresholds to operational effectiveness, the mandate may be premature.
Some progressive groups have also raised concerns about potential implications for transgender service members whose hormone levels are medically managed. They argue that singling out testosterone as a metric could complicate existing policies governing service by transgender individuals.
"We should be focused on actual metrics of combat readiness, not arbitrary hormone thresholds," said one Democratic staffer familiar with the matter who spoke on condition of anonymity to discuss internal deliberations.
What the Numbers Show
The Defense Department has not released data on how many troops would be affected by the new testing requirement. Current active-duty military strength stands at approximately 1.3 million service members across all branches, with a significant portion falling into the over-30 age category.
Testosterone levels naturally decline in men at a rate of roughly 1 to 2 percent per year after age 30, according to data from the Endocrine Society. Medical literature indicates that normal ranges vary widely among healthy individuals, and clinical thresholds for diagnosis differ from population averages.
The Pentagon has not specified what testosterone threshold would trigger any action or further evaluation. No budget estimate for implementing the new screening program has been publicly released as of this reporting.
Military health expenditure totaled approximately $49 billion in fiscal year 2025, according to Defense Health Agency figures. The incremental cost of adding hormone testing to existing blood panels remains unknown.
The Bottom Line
The Pentagon's testosterone mandate represents a notable expansion of military health screening protocols. Whether it improves troop readiness or becomes a administrative burden will depend on how the program is implemented and what actions follow positive test results.
Medical experts say they await further guidance from the Defense Department on clinical protocols, treatment pathways for out-of-range results, and privacy protections for service members' personal health data. The policy could face legal challenges if implementation raises constitutional or statutory concerns.
Congressional oversight of the directive is expected as appropriators review defense health programs. Lawmakers in both parties have said they want more details before rendering judgment on whether the initiative merits continued funding.